Full translation summary from PharmAsia News - January 22, 2009
The medical device sector of Australia's biotech industry is the most successful sector, as demonstrated by AtCor Medical's report of a 76 percent increase in interim sales.
Medical Device Makers Drive Australia’s Biotech Sector Gains
The company said its sales increase was driven in a large part by its SphygmoCor devices for measuring blood pressure. The report belies the economic slowdown Australia is experiencing along with the rest of the world. U.S. sales alone accounted for a125 percent increase in the company's sales as pharmaceutical companies sought central blood-pressure measurements for clinical trials.
PharmAsia News covers drugs, biotech and devices in the Pacific Rim.
PharmAsia News brings you the news and analysis you need to succeed in the competitive global marketplace. Sign up for 30-day, risk-free trial of PharmAsia News online or call 1-800-332-2181.
